New EU Commissioner Outlines Plans To Tackle Shortages
Executive Summary
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
You may also be interested in...
EU Drug Shortage Network Pilot Moves Into Second Phase
A single point of contact network that is expected to help EU countries share information on medicines shortages has completed its first phase and will be spread more widely this year.
EU Evaluation Of Orphan & Pediatric Legislation Nears Completion
Spring 2020 should see the publication of a working document by the European Commission on how to improve the operation of the EU legislation on orphan and pediatric medicines. The commission has asked for more input from member state experts.
Drug Shortages, AMR & Cancer High On New EU Commissioner’s Agenda
The new EU commissioner for health has been given a number of high-priority tasks, including medicines supply and tackling antimicrobial resistance. These topics will be taken up by the European Commission’s advisory body, the Pharmaceutical Committee, in its new work plan.